Back to search

United Kingdom· GB-APID-10928811000001102

Bisodol Extra tablets

A magaldrate product containing magaldrate, registered in United Kingdom by Forest Laboratories UK Ltd. The same ATC class is registered in 6 of our 19 countries.

ATC A02AD02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedBisodol Extra tabletsATCA02AD02REGISTER NO.GB-APID-1092881100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Magaldrate is registered in 6 of 19 countries.

Countries holding a registration under ATC A02AD02 (magaldrate), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 4 of them publish a price we can compare per daily dose

Magaldrate · ATC A02AD02

6 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Germany
  • Italyprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of magaldrate costs, country by country.

Normalised to the WHO defined daily dose (3.2 g), the median price runs from $0.54 in Italy to $1.43 in Switzerland — a ×2.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Magaldrate · price per daily dose (3.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.43
  • IT Italy$0.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Magaldrate
Manufacturer
Forest Laboratories UK Ltd
Country
United Kingdom (GB)
ATC code
A02AD02
ATC class
Magaldrate
Defined daily dose
3.2 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

223 interactions on record for magaldrate.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Magaldrate · interactions on record

223 records

  • 8 severe
  • 106 moderate
  • 93 minor

Most severe, free to view

  • RaltegravirJ05AJ01severe
  • DolutegravirJ05AJ03severe
  • RaltegravirJ05AX08severe
  • DolutegravirJ05AX12severe

16 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Magaldrate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magaldrate products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Austria · Riopan
  • Belgium · Riopan
  • Germany · Magaldrat Ratiopharm, Riopan Btl
  • Spain · Bemolan, Magión
  • Greece · Riopan
  • Italy · Gadral, Magaldrato Doc
  • Luxembourg · Riopan
  • Portugal · Riopan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fdddae89-003c-49c5-8d4c-06409850c6e1
GET /v1/drugs/fdddae89-003c-49c5-8d4c-06409850c6e1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "10928811000001102",
  "desc": "Bisodol Extra tablets (Forest Laboratories UK Ltd)",
  "form": "Oral tablet",
  "vpid": "4598511000001101",
  "source": "dmd",
  "vtm_id": null,
  "strength": "400 mg",
  "substance": null,
  "ingredient": "Magaldrate",
  "supplier_code": "2082801000001107"
}

See everything about magaldrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.